Uncategorized

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity – Investors | Eli Lilly and Company

Posted on Author Comments Off on FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity – Investors | Eli Lilly and Company
  1. FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity  Investors | Eli Lilly and Company
  2. The popular weight-loss drug Zepbound can now be used to treat sleep apnea  USA TODAY
  3. F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea  The New York Times
  4. FDA approves weight-loss drug Zepbound for obstructive sleep apnea  CNN
  5. FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.  CNBC